NR AOCO
AU Ricketts,M.N.; Brown,P.
TI Transmissible spongiform encephalopathy update and implications for blood safety
QU Clinics in Laboratory Medicine 2003 Mar; 23(1): 129-37
PT journal article; review; review, academic
AB At this time, the accumulated evidence does not support the implementation of measures targeted against the risk of transfusion transmission of sporadic, familial, or iatrogenic CJD. Evolving information about vCJD, however, suggests that policy makers need to consider implementing measures to protect against exposure to vCJD, if such measures themselves do not lead to decreased blood safety. Surveillance of human TSEs and investigation of the risk of transfusion transmission must continue in order to provide further refinements in blood safety policy.
ZR 110
MH *Blood Banks; *Blood Transfusion/adverse effects; Creutzfeldt-Jakob Syndrome/epidemiology/*etiology; *Disease Transmission, Horizontal; Human; Prion Diseases/epidemiology/*transmission
AD World Health Organization, Room L412, Ave Appia, Geneva, Switzerland. rickettsm@who.ch
SP englisch
PO USA